Recent developments in biotech include challenges faced by Radiopharma regarding toxicity issues despite its precision promise, new regulatory measures in…
Browsing: Key
Key developments in the pharmaceutical industry for 2026 reveal a mix of regulatory changes and market trends aimed at improving…
Moleculin Biotech has announced a public stock offering priced at 75 cents per share to raise $9.3 million for its…
TrivarX Limited (ASX:TRI) has secured the stable isotope compound needed for its upcoming Phase 1 trial of the Stabl-IM imaging…
At the 2025 NSF Pharma Biotech Conference, a Q&A session delved into enhancing contamination control strategies (CCS) and fostering a…
Takeda Pharmaceutical has recently garnered attention following multiple regulatory and pipeline advancements, especially in rare diseases and oncology. The company…
Caris Life Sciences, Inc. held its 2026 Annual Meeting of Shareholders on June 4, 2026, where key developments included the…
Last month, the FDA approved Regeneron’s Otarmeni, a groundbreaking gene therapy for specific hearing loss, signaling a shift in focus…
Aurion Biotech, a regenerative cell therapy company focused on restoring vision, announced it will present at two major ophthalmology conferences…
On April 24, 2026, Health Canada announced that as of April 1, 2026, manufacturers must use the Regulatory Enrolment Process…